Anika Therapeutics Inc Sustainability Reports
Anika Therapeutics, Inc. is a joint preservation company that develops, manufactures, and commercializes early intervention orthopedic solutions. Its products are primarily based on hyaluronic acid technology and are designed for osteoarthritis pain management and regenerative therapeutics.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900R9LS3Z0O6QH455
FIGI: BBG001S609X7
14 reports from 2008 to 2025
